Literature DB >> 33952503

Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus.

Sangjoon Choi1, Kiyong Na2, So-Woon Kim3, Hyun-Soo Kim4.   

Abstract

BACKGROUND/AIM: We present a case of uterine dedifferentiated mesonephric-like adenocarcinoma (MLA). CASE REPORT: A 54-year-old woman underwent total hysterectomy for a uterine mass under the impression of a uterine sarcoma. Histologically, MLA exhibited various growth patterns including tubular and glandular architecture. Undifferentiated carcinoma (UC) displayed discohesive tumor cells without any obvious architecture. Immunohistochemically, UC was positive for epithelial markers in very few scattered tumor cells. MLA exhibited the wild-type p53 expression pattern, whereas UC showed a uniform and strong p53 immunoreactivity. Targeted sequencing analysis revealed an identical Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in both components. A pathogenic missense tumor protein 53 (TP53) mutation was detected in UC, but not in MLA.
CONCLUSION: The mutant p53 expression pattern exclusively detected in UC was concordant with the presence of missense TP53 mutation. Our observations suggested that TP53 mutation is associated with the possible transformation from MLA to UC.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Uterus; dedifferentiated carcinoma; mesonephric-like adenocarcinoma; undifferentiated carcinoma

Year:  2021        PMID: 33952503     DOI: 10.21873/anticanres.15053

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

Review 1.  Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.

Authors:  Han Gyeol Kim; Hyunjin Kim; Min-Kyung Yeo; Kyu Yeoun Won; Young Sun Kim; Gwan Hee Han; Hyun-Soo Kim; Kiyong Na
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

2.  Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.

Authors:  Tianshi Ma; Mengyu Chai; Huafeng Shou; Guoqing Ru; Ming Zhao
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

3.  Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.

Authors:  Hyunjin Kim; Go Eun Bae; Yoon Yang Jung; Hyun-Soo Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

4.  Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.

Authors:  Sangjoon Choi; So-Woon Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

5.  Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation.

Authors:  Hyunjee Lee; Hyunjin Kim; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-05

6.  Extraskeletal Mesenchymal Chondrosarcoma of the Uterus.

Authors:  Yurimi Lee; Sangjoon Choi; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.